\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ soft\\ fontanelle\ \(0\)\
\-\ \\â\\€\\¢\\ normal\\ cranial\\ sutures\ \(0\)\
\-\ chemotherapy\\ planned\ \(0\)\
\-\ complex\\,\\ \\ large\\ mass\\ right\\ frontal\\ lobe\\ with\\ associated\\ hemorrhage\\ and\\ both\\ fluid\\ and\\ solid\\ components\\.\ \(0\)\
\-\ mass\\ enhances\\ minimally\\ following\\ contrast\\ administration\\.\ \(0\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ \\â\\€\\¢\\ gliosarcoma\ \(0\)\
\-\ \\â\\€\\¢\\ pnet\\ \\(cerebral\\ neuroblastoma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ atypical\\ teratoid\\/rhabdoid\\ tumor\ \(1\)\
\-\ \\â\\€\\¢\\ teratoma\ \(2\)\
\-\ newborn\\ female\\ who\\ was\\ transferred\\ from\\ a\\ local\\ hospital\\ because\\ a\\ prenatal\\ ultrasound\\ showed\\ hydrocephalus\\ and\\ a\\ mass\\.\ \(0\)\
\-\ congenital\\ brain\\ tumors\\ are\\ rare\\ with\\ gbm\\ accounting\\ for\\ a\\ minority\\ of\\ them\\.\\ \\ the\\ most\\ common\\ congenital\\ brain\\ tumors\\ are\\ teratoma\\,\\ pnet\\ \\(incl\\.\\ medulloblastoma\\)\\,\\ astrocytoma\\ \\(incl\\.\\ gbm\\)\\,\\ and\\ choroid\\ plexus\\ papilloma\\.\\ pmid\\:\\ 2167004\ \(0\)\
\-\ glioblastomas\\ are\\ most\\ commonly\\ diagnosed\\ in\\ middle\\ aged\\ to\\ older\\ adults\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ incl\\:\\ 0\\.14104829478346398\ \(0\)\
\-\ pnet\\:\\ 0\\.08284691622784181\ \(0\)\
\-\ gbm\\:\\ 0\\.08086909293236696\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.07521668887660261\ \(0\)\
\-\ glioblastomas\\:\\ 0\\.07052414739173199\ \(0\)\
\-\ 2167004\\:\\ 0\\.06497896994725243\ \(0\)\
\-\ teratoma\\:\\ 0\\.06392378973378338\ \(0\)\
\-\ minority\\:\\ 0\\.057648644092259185\ \(0\)\
\-\ teratoid\\/rhabdoid\\:\\ 0\\.05495686619928948\ \(0\)\
\-\ gliosarcoma\\:\\ 0\\.0538886150582933\ \(0\)\
\-\ tumors\\:\\ 0\\.051355461722728014\ \(0\)\
\-\ congenital\\:\\ 0\\.050002543514279005\ \(0\)\
\-\ fontanelle\\:\\ 0\\.04834343761381373\ \(0\)\
\-\ sutures\\:\\ 0\\.046968635558400466\ \(0\)\
\-\ accounting\\:\\ 0\\.04655828920330006\ \(0\)\
\-\ aged\\:\\ 0\\.045099716748948415\ \(0\)\
\-\ pmid\\:\\ 0\\.04305224975585082\ \(0\)\
\-\ them\\:\\ 0\\.041855995884083105\ \(0\)\
\-\ brain\\:\\ 0\\.041141624372844195\ \(0\)\
\-\ multiforme\\:\\ 0\\.03972296657805152\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.03972296657805152\ \(0\)\
\-\ planned\\:\\ 0\\.038914197643080566\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.03763715647834549\ \(0\)\
\-\ newborn\\:\\ 0\\.03725308272485461\ \(0\)\
\-\ prenatal\\:\\ 0\\.03712904923256689\ \(0\)\
\-\ transferred\\:\\ 0\\.03676808575032313\ \(0\)\
\-\ minimally\\:\\ 0\\.035568564571995816\ \(0\)\
\-\ choroid\\:\\ 0\\.03488936902170392\ \(0\)\
\-\ adults\\:\\ 0\\.03488936902170392\ \(0\)\
\-\ older\\:\\ 0\\.03443727133959719\ \(0\)\
\-\ papilloma\\:\\ 0\\.03434983877533966\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.03417778913357196\ \(0\)\
\-\ components\\:\\ 0\\.03352436488545781\ \(0\)\
\-\ plexus\\:\\ 0\\.03321663463883545\ \(0\)\
\-\ enhances\\:\\ 0\\.03229115944683975\ \(0\)\
\-\ most\\:\\ 0\\.031565362267649215\ \(0\)\
\-\ local\\:\\ 0\\.03140135436595796\ \(0\)\
\-\ cranial\\:\\ 0\\.029725215969138397\ \(0\)\
\-\ atypical\\:\\ 0\\.029628245084879642\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.029390838939710704\ \(0\)\
\-\ mass\\:\\ 0\\.02852306416674155\ \(0\)\
\-\ administration\\:\\ 0\\.028381282119225363\ \(0\)\
\-\ are\\:\\ 0\\.027956972940710444\ \(0\)\
\-\ complex\\:\\ 0\\.027375127020913093\ \(0\)\
\-\ solid\\:\\ 0\\.027266773220051038\ \(0\)\
\-\ rare\\:\\ 0\\.02654680158938637\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.02654680158938637\ \(0\)\
\-\ commonly\\:\\ 0\\.02579625154764513\ \(0\)\
\-\ hospital\\:\\ 0\\.025736771719744988\ \(0\)\
\-\ diagnosed\\:\\ 0\\.025137561254360046\ \(0\)\
\-\ middle\\:\\ 0\\.025001271757139502\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02450356628112692\ \(0\)\
\-\ because\\:\\ 0\\.023916146532688386\ \(0\)\
\-\ cerebral\\:\\ 0\\.02368357201411257\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.022754052673408284\ \(0\)\
\-\ showed\\:\\ 0\\.022414426143389572\ \(0\)\
\-\ frontal\\:\\ 0\\.02147433547586686\ \(0\)\
\-\ ultrasound\\:\\ 0\\.020280980680050426\ \(0\)\
\-\ fluid\\:\\ 0\\.019429112836830825\ \(0\)\
\-\ following\\:\\ 0\\.019402222055209188\ \(0\)\
\-\ lobe\\:\\ 0\\.018394602783388274\ \(0\)\
\-\ common\\:\\ 0\\.017890137695651176\ \(0\)\
\-\ who\\:\\ 0\\.017823747273133617\ \(0\)\
\-\ both\\:\\ 0\\.01745759992548897\ \(0\)\
\-\ \\(\\:\\ 0\\.017336681429852653\ \(0\)\
\-\ \\)\\:\\ 0\\.017124904610719322\ \(0\)\
\-\ soft\\:\\ 0\\.0166474141119484\ \(0\)\
\-\ associated\\:\\ 0\\.016131700495261615\ \(0\)\
\-\ tumor\\:\\ 0\\.01593785841288649\ \(0\)\
\-\ contrast\\:\\ 0\\.015302205494463242\ \(0\)\
\-\ large\\:\\ 0\\.014948339454648638\ \(0\)\
\-\ female\\:\\ 0\\.014054082171582669\ \(0\)\
\-\ a\\:\\ 0\\.012691193658195241\ \(0\)\
\-\ normal\\:\\ 0\\.010716899636792808\ \(0\)\
\-\ from\\:\\ 0\\.010131485705233699\ \(0\)\
\-\ \\:\\:\\ 0\\.009042198527925321\ \(0\)\
\-\ \\,\\:\\ 0\\.008662722096553197\ \(0\)\
\-\ was\\:\\ 0\\.007906220177709495\ \(0\)\
\-\ right\\:\\ 0\\.007213053672883334\ \(0\)\
\-\ for\\:\\ 0\\.005832865189141721\ \(0\)\
\-\ and\\:\\ 0\\.005760288183430991\ \(0\)\
\-\ to\\:\\ 0\\.00341654486754389\ \(0\)\
\-\ in\\:\\ 0\\.0033711778411220396\ \(0\)\
\-\ \\.\\:\\ 0\\.0022719703102301618\ \(0\)\
\-\ with\\:\\ 0\\.0018720668174382357\ \(0\)\
\-\ the\\:\\ 0\\.0011059942776290065\ \(0\)\
\-\ of\\:\\ 0\\.0009320304063839075\ \(0\)\
